PNC-27 (5mg)

$142.00

PNC-27 (5mg) is offered by Biotech Peptides for laboratory and analytical research. PNC-27 is a synthetic 32-residue peptide containing an HDM-2-binding domain derived from p53 residues 12-26 and a membrane-residency peptide, studied in relation to cancer-cell membrane lysis. 1122

  • Product: PNC-27

  • Alternative name: Membrane Residency Peptide

  • Listed quantity: 5 mg

  • Reference molecular formula: C₁₈₈H₂₉₃N₅₃O₄₄S

  • Intended use: Laboratory and analytical research only

Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.

For research use only. Not for human consumption.

SKU: PNC-27-5mg Category:
Description

PNC-27 (5mg) for Laboratory Research

PNC-27 (5mg) is offered by Biotech Peptides for laboratories investigating HDM-2 binding, cancer-cell membrane lysis, and peptide-mediated cytotoxicity. PNC-27 is a synthetic 32-residue peptide containing an HDM-2-binding domain derived from p53 residues 12-26 and a membrane-residency peptide. 1122

For laboratories looking to buy PNC-27, this listing identifies a 5 mg quantity. Confirm the supplied material’s salt state, stereochemistry, and analytical characteristics against the requirements of the intended work.

Explore our research peptides for sale to review other laboratory-use listings.

PNC-27 Product Information

Property Listing information
Product name PNC-27
Alternative name Membrane Residency Peptide
Listed quantity 5 mg
Intended application Laboratory and analytical research
Documentation inquiries Include the product name and batch or lot number, where available

The 5 mg designation describes the quantity stated for this listing. It does not independently establish net peptide content or confirm that a particular quantity-assay method has been performed.

PNC-27 Reference Molecular Characteristics

The following characteristics describe the PNC-27 reference structure. They are not analytical confirmation of an individual commercial batch.

Reference characteristic Information
Peptide length 32 residues
Reference sequence H-Pro-Pro-Leu-Ser-Gln-Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-Lys-Lys-Trp-Lys-Met-Arg-Arg-Asn-Gln-Phe-Trp-Val-Lys-Val-Gln-Arg-Gly-OH
Molecular formula C₁₈₈H₂₉₃N₅₃O₄₄S
Approximate molecular weight 4031.7 g/mol
CAS number 1159861-00-3
Chemical class Synthetic hybrid polypeptide

The sequence, molecular formula, molecular weight, and CAS number are documented in the PubChem PNC-27 reference record and in the PNC-27 research summary. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations. 1124

PNC-27 and HDM-2 Binding Research

A study of PNC-27 and HDM-2 binding reported that PNC-27 targets HDM-2 in the membranes of cancer cells, allowing it to induce membranolysis of these cells selectively. The investigators reported that PNC-27 induces cancer cell cytotoxicity by a previously undescribed mechanism in which the peptide induces cancer cell membranolysis that appears to depend on the binding of the peptide to HDM-2 in the cancer cell membrane. 1122

A separate study of PNC-27 and HDM-2 binding reported that PNC-27 is a 32-residue peptide that contains an HDM-2 binding domain and a cell-penetrating peptide leader sequence that kills cancer, but not normal, cells by binding to HDM-2 associated with the plasma membrane and induces the formation of pores causing tumor cell lysis and necrosis. 1125

Read the primary PNC-27 HDM-2 binding study for the experimental design and limitations.

Cancer-Cell-Line Research

A study of PNC-27 and leukemia cells reported that PNC-27 binds to HDM-2 protein on cancer cell membranes inducing the formation of cytotoxic transmembrane pores. The investigators reported that PNC-27 is composed of amino acid residues 12-26 of the HDM-2 binding domain of p53 on its amino terminus and a membrane residency peptide on its carboxyl terminus. 1131

A separate study of PNC-27 and cervical cancer reported that PNC-27 is an anti-cancer peptide that contains the HDM-2-binding domain of the p53 protein, residues 12-26, attached to a transmembrane-penetrating peptide from antennapedia. The investigators reported that PNC-27 binds to membrane-expressed HDM-2 in cancer cells resulting in association of PNC-27-HDM-2 complexes that line trans-membrane pores that induce rapid tumor cell necrosis. 1128

These findings apply to specific cancer-cell-line models and exposure protocols. They do not establish that PNC-27 treats cancer, prevents cancer, or produces a cosmetic effect in humans. 1122

Research Limitations

Published PNC-27 research examines cell-based assays, rodent models, and limited cancer-cell-line contexts. It does not establish that PNC-27 treats cancer, prevents cancer, or treats any condition. 1122

Published research also does not verify the identity, purity, quantity, or biological activity of the commercial batch supplied with this listing.

Documentation and Batch Verification

Before selecting PNC-27 (5mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:

  • Product name and batch or lot identifier.

  • Manufacturer specifications and chemical form.

  • Salt state and counterion information, where applicable.

  • Identity-testing methods and reported results.

  • Purity-testing methods and supporting analytical data.

  • Quantity or peptide-content measurements, where required.

  • Product-specific storage and handling instructions.

Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent names, sequences, or molecular values.

For inquiries, provide “PNC-27 (5mg),” the batch number where available, and the specific information your laboratory requires.

Storage and Handling

Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.

Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.

Frequently Asked Questions About PNC-27 (5mg)

What is PNC-27?

PNC-27 is a synthetic 32-residue peptide containing an HDM-2-binding domain derived from p53 residues 12-26 and a membrane-residency peptide. 1122

Is PNC-27 the same as membrane residency peptide?

No. PNC-27 is a synthetic hybrid polypeptide that contains a membrane-residency peptide. It is not the same molecule as membrane residency peptide. 1122

Does PNC-27 kill cancer cells?

A study of PNC-27 and HDM-2 binding reported that PNC-27 targets HDM-2 in the membranes of cancer cells, allowing it to induce membranolysis of these cells selectively. This does not establish that a commercial PNC-27 batch kills cancer cells in humans. 1122

What does the 5mg designation mean?

It is the quantity stated for this listing. It does not describe a concentration or independently establish net peptide content.

Does published research verify this product?

No. Publications describe the materials and conditions used by the investigators. Assess a commercial batch using relevant manufacturer specifications and analytical evidence.

Where can I find delivery information?

Review our shipping information for current order-processing and delivery terms.

Research Use Only

PNC-27 (5mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.

Review our Research-Use-Only Policy before ordering.

Additional information
BrandBiotech Peptides
Shipping & Delivery